Cognition Studio, Inc.

TriSalus: SD-101 and SmartValve Technology 

Prev Next
Previous

Telios Pharma - TL-895 MOA at EHA 2023

Next medical animation of TriSalus Life Sciences' PEDD method enhances tumor targeting and therapeutic delivery, as proven by clinical evidence. This award-winning animation combines 'desktop anatomy models' with data visualization, bringing these data to life.

TriSalus - PEDD Evidence Summary Video

TriSalus takes an integrated approach tailored to the target organ and disease biology to overcome two critical barriers: immunosuppression and delivery. This composite video tells the complexity of TriSalus' story by communicating the value of SD-101, a therapeutic that delivers organ-specific immunomodulation, and SmartValve™ technology, a regional intravascular, Pressure-Enabled Drug Delivery approach to increase therapeutic value and support better patient outcomes.

Keywords: Animation, 3D, Advertising / Marketing, Editorial, Biotechnology, Cell biology / Histology, Medical Devices, Molecular Biology, Oncology, Mechanism of Action (MOA)

TriSalus Life Sciences